Medication info
Rosuduo Tablet 10/10 mg (Ezetimibe, Rosuvastatin Calcium)

Rosuduo Tablet 10/10 mg (Ezetimibe, Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
White to nearly white round film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP × 3]
Approval status
Active

MFDS item code 202004142 · Approved 2020.05.29 · Insurance code 647304330

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL-cholesterol
  • increased Apo B protein
  • increased triglycerides
  • increased non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease attributable to hypercholesterolemia
  • dyslipidemia
  • diabetes
View approved original text

This medication effectively lowers total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while helping to increase HDL-cholesterol levels. It is used as an adjunct to diet in order to reduce the risk of atherosclerotic vascular disease. Before use, it is important to identify and treat any secondary causes of dyslipidemia if necessary. Drug therapy should be combined with an appropriate diet that limits saturated fat and cholesterol and is applied when there is insufficient response to non-drug therapy. Additionally, in patients with acute coronary events, lipid testing should be performed upon admission or within 24 hours after admission to decide on treatment direction. This medication is effectively used to improve hypercholesterolemia.

How to take

Adult dose

This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may affect muscles, so if severe muscle pain or weakness occurs, consult a physician immediately. Care should be taken as rhabdomyolysis, a severe muscle damage condition, can occur rarely. Patients with severe infections, hypotension, major surgery, trauma, metabolic abnormalities, and other conditions that present a high risk of muscle damage may need to temporarily discontinue this medication. Patients with allergies to any of the ingredients in this medication or those with significantly impaired liver function, muscle disorders, severely reduced kidney function, and those who are pregnant or breastfeeding should not take this medication. Additionally, the risk of muscle damage may increase when taken with certain medications, so if you are taking other drugs, be sure to inform your physician. This medication may affect liver function, so liver function tests should be performed before and during treatment, and any symptoms of liver function abnormalities should be reported immediately. Elderly patients or those with hypothyroidism, renal function impairment, etc., have a higher risk of muscle damage and should be monitored closely. This medication should not be administered to pregnant women or those who may become pregnant, and women of childbearing age should use appropriate contraception during treatment. Symptoms such as dizziness or headache may occur, so caution is needed when driving or operating machinery. If muscle pain, fatigue, or fever accompanies symptoms while taking this medication, you should inform healthcare personnel immediately, and blood tests may be needed to check for muscle damage. This medication is not recommended for children as safety and efficacy have not been adequately established. In case of overdose, since no specific antidote is available, appropriate treatment and supportive care based on symptoms are necessary, and liver function and muscle-related tests should be performed. This medication should be kept out of the reach of children, and it is recommended not to transfer it to another container.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, strange sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucose load impairment, depression, bronchitis, rhinitis, cystitis, dermatophyte infections of nails, soft tissue infections, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, pain in the oropharynx, nasal congestion, respiratory difficulties, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal impairment, benign esophageal neoplasms, angioedema, vascular edema, hypersensitivity reactions, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS), lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, memory decline, amnesia, memory loss, memory disorders, confusion, severe muscle weakness, ocular myasthenia, increased CK, chest pain, discomfort in the chest, systemic edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastrium, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, hyperhidrosis, upper respiratory infection, conjunctival congestion, renal failure, liver function abnormalities, increased serum creatinine, elevated blood pressure, increased blood urea, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help ensure the safety and effectiveness of the medication.

Appearance and packaging

Appearance

White to nearly white round film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.